| Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7 A Vergani, S Tezza, F D’Addio, C Fotino, K Liu, M Niewczas, R Bassi, ... Circulation 127 (4), 463-475, 2013 | 130 | 2013 |
| Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: neurophysiological and skin biopsy longitudinal analysis U Del Carro, P Fiorina, S Amadio, L De Toni Franceschini, A Petrelli, ... Diabetes care 30 (12), 3063-3069, 2007 | 122 | 2007 |
| PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation A Petrelli, G Mijnheer, DPH van Konijnenburg, MM Van Der Wal, ... The Journal of clinical investigation 128 (10), 4669-4681, 2018 | 99 | 2018 |
| CD8+ T cells in human autoimmune arthritis: the unusual suspects A Petrelli, F Van Wijk Nature Reviews Rheumatology 12 (7), 421-428, 2016 | 93 | 2016 |
| Targeting the CXCR4–CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1 P Fiorina, M Jurewicz, A Vergani, A Petrelli, M Carvello, F D’Addio, ... The Journal of Immunology 186 (1), 121-131, 2011 | 88 | 2011 |
| A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice A Vergani, F D'Addio, M Jurewicz, A Petrelli, T Watanabe, K Liu, K Law, ... diabetes 59 (9), 2253-2264, 2010 | 84 | 2010 |
| Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression G Sebastiani, G Ventriglia, A Stabilini, C Socci, C Morsiani, A Laurenzi, ... Scientific reports 7 (1), 6897, 2017 | 59 | 2017 |
| The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes J Azzi, RF Moore, W Elyaman, M Mounayar, N El Haddad, S Yang, ... diabetes 61 (6), 1509-1518, 2012 | 42 | 2012 |
| Strategies to reverse endothelial progenitor cell dysfunction in diabetes A Petrelli, R Di Fenza, M Carvello, F Gatti, A Secchi, P Fiorina Journal of Diabetes Research 2012, 2012 | 42 | 2012 |
| IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response A Petrelli, M Carvello, A Vergani, KM Lee, S Tezza, M Du, S Kleffel, ... Diabetes 60 (12), 3223-3234, 2011 | 37 | 2011 |
| Generation of donor-specific T regulatory type 1 cells from patients on dialysis for cell therapy after kidney transplantation A Petrelli, E Tresoldi, BG Mfarrej, A Paganelli, D Spotti, R Caldara, ... Transplantation 99 (8), 1582-1589, 2015 | 32 | 2015 |
| Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: a cross-sectional analysis of the effect of … P Fiorina, G Perseghin, F De Cobelli, C Gremizzi, A Petrelli, L Monti, ... Diabetes Care 30 (3), 597-603, 2007 | 30 | 2007 |
| Self‐Sustained Resistance to Suppression of CD8+ Teff Cells at the Site of Autoimmune Inflammation Can Be Reversed by Tumor Necrosis Factor and Interferon‐γ Blockade A Petrelli, EJ Wehrens, RC Scholman, BJ Prakken, SJ Vastert, F van Wijk Arthritis & Rheumatology 68 (1), 229-236, 2016 | 26 | 2016 |
| Improved function of circulating angiogenic cells is evident in type 1 diabetic islet-transplanted patients A Petrelli, A Maestroni, GP Fadini, D Belloni, M Venturi, M Albero, S Kleffel, ... American Journal of Transplantation 10 (12), 2690-2700, 2010 | 26 | 2010 |
| Metabolic and immunological features of the failing islet-transplanted patient P Fiorina, A Vergani, A Petrelli, F D'Addio, L Monti, R Abdi, E Bosi, P Maffi, ... Diabetes Care 31 (3), 436-438, 2008 | 26 | 2008 |
| Metabolic and immunological features of the failing islet-transplanted patient P Fiorina, A Vergani, A Petrelli, F D'Addio, L Monti, R Abdi, E Bosi, P Maffi, ... Diabetes Care 31 (3), 436-438, 2008 | 26 | 2008 |
| Contribution of polymeric materials to progress in xenotransplantation of microencapsulated cells: a review R Mahou, S Passemard, M Carvello, A Petrelli, F Noverraz, ... Xenotransplantation 23 (3), 179-201, 2016 | 25 | 2016 |
| Inotuzumab ozogamicin murine analog–mediated B-cell depletion reduces anti-islet allo-and autoimmune responses M Carvello, A Petrelli, A Vergani, KM Lee, S Tezza, M Chin, E Orsenigo, ... Diabetes 61 (1), 155-165, 2012 | 21 | 2012 |
| Developing translational medicine professionals: the Marie Skłodowska-Curie action model A Petrelli, BJ Prakken, ND Rosenblum, EUtrain fellows Journal of Translational Medicine 14, 1-4, 2016 | 7 | 2016 |
| Women in translational medicine: Tools to break the glass ceiling SH Bots, MGP Zuidgeest, A Gohar, ALM Eikendal, A Petrelli, ... Frontiers in medicine 5, 330, 2018 | 6 | 2018 |
